Tyrosinemia type I: long-term outcome in a patient treated with doses of NTBC lower than recommended

被引:4
作者
D'Eufemia, Patrizia [1 ]
Celli, Mauro [1 ]
Tetti, Martina [1 ]
Finocchiaro, Roberto [1 ]
机构
[1] Univ Roma La Sapienza, Dept Pediat, I-00161 Rome, Italy
关键词
Liver Injury; Average Dose; Actual Dose; Corneal Opacity; Tyrosinemia;
D O I
10.1007/s00431-011-1419-4
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:819 / 819
页数:1
相关论文
共 2 条
  • [1] Clinical practice - NTBC therapy for tyrosinemia type 1: how much is enough?
    El-Karaksy, Hanaa
    Rashed, Mohmmad
    El-Sayed, Rokaya
    El-Raziky, Mona
    El-Koofy, Nehal
    El-Hawary, Manal
    Al-Dirbashi, Osama
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2010, 169 (06) : 689 - 693
  • [2] Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione)
    Holme, E
    Lindstedt, S
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (05) : 507 - 517